Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Regeneron to retrofit Dell's Ireland facility for manufacturing drugs

PBR Staff Writer Published 28 August 2013

Biopharmaceutical company Regeneron Pharmaceuticals is set to retrofit a former Dell 400,000 ft2 computer site in Limerick, Ireland as its second manufacturing facility.

Regeneron corporate communications vice president Peter Dworkin was quoted by FiercePharmaManufacturing as saying, "It will become a second manufacturing site, after our site in Rensselaer.

"Ireland is part of the EU so obviously it gives us the opportunity to more closely supply our partners from Europe," Dworkin added.

The acquisition is subject to approvals from local authorities, while products to be manufactured remain undecided.

In quarterly financial filing 2013, the company said, "We intend to renovate this facility to accommodate and support our growth, primarily in connection with expanding our manufacturing capacity to support our global supply chain."

According to SEC filing, the company expects to invest nearly $250m to $300m on capital projects through 2014, which also includes facility acquisition and retrofit work.

Comments
Post a comment

Comments may be moderated for spam, obscenities or defamation.